EHA 2026: Germline Testing Beyond Family History in AML and MDS
/ Panagiotis Baliakas
EHA 2026: Teclistamab Outcomes in High-Risk Extramedullary Myeloma
/ Astrid Hundebøll Torpe
EHA 2026: Increased Risk of Psychotropic Drug Use Observed in Patients with Mastocytosis
/ Maren Poulsgaard Jørgensen
EHA 2026: Comparable Outcomes with Reduced-Dose Treosulfan
/ Johanne Skovgaard Schovsbo











